Yulin Ren

Statistics

Publications

Citations

166

H-Index

Active since

2013

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Hangzhou DAC Biotech (China)

Yulin Ren is an author at Tianjin Medical University Cancer Institute and Hospital specializing in immunology, cancer immunotherapy, and life sciences.

Publications per year

2013–2023

Publications

Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)

Zhenzhen Hui, Jiali Zhang, Yulin Ren et al. · Cell Death and Disease · 2022 · 64 citations · Full text

Life Sciences, Immunology, Oncology +17

CD4+ T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer

Shaochuan Liu, Yuan Meng, Liang Liu et al. · Cell Death and Disease · 2022 · 44 citations · Full text

Life Sciences, Immunology, Oncology +17

The L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral Replication

Yu Zhang, Yulin Ren, Yan Wu et al. · Journal of Virology · 2013 · 25 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells

Zhenzhen Hui, Yulin Ren, Dong Zhang et al. · npj Precision Oncology · 2023 · 23 citations · Full text

Medicine, Immunology, Oncology +17

Non-spatial and spatial heterogeneity revealed a suppressive immune feature of Siglec-15 in lung adenocarcinomas

Baihui Li, Yan Guo, Yeran Yi et al. · Journal of Translational Medicine · 2023 · 10 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 5